Literature DB >> 3277709

Recombinant interferon alfa-2b (Intron A) as post-induction therapy for responding multiple myeloma patients. M84 protocol.

F Mandelli1, M Tribalto, G Avvisati, M Cantonetti, M T Petrucci, M Boccadoro, A Pileri, F Marmont, L Resegotti, V Lauta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3277709     DOI： 10.1016/0305-7372(88)90073-4

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  9 in total

1.  Appropriate chemotherapy for palliating advanced cancer.

Authors:  M S Hamilton
Journal:  BMJ       Date:  1992-02-01

Review 2.  Haematology.

Authors:  N T O'Connor
Journal:  Postgrad Med J       Date:  1990-08       Impact factor: 2.401

3.  Defective interleukin-2 induction of lymphokine-activated killer (LAK) activity in peripheral blood T lymphocytes of patients with monoclonal gammopathies.

Authors:  M Massaia; A Bianchi; U Dianzani; A Camponi; C Attisano; M Boccadoro; A Pileri
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

4.  Low-dose interferon-alpha in stage-I multiple myeloma and in IgM monoclonal gammopathy. Eastern Cooperative Study Group on Monoclonal Gammopathies.

Authors: 
Journal:  Ann Hematol       Date:  1992-03       Impact factor: 3.673

5.  Multiple myeloma: biology and therapy.

Authors:  B Barlogie; J Epstein
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

Review 6.  Problems in the management of myeloma.

Authors:  J S Malpas
Journal:  Postgrad Med J       Date:  1989-07       Impact factor: 2.401

Review 7.  Management of multiple myeloma.

Authors:  B Barlogie
Journal:  Blut       Date:  1990-01

8.  Interferon alfa-2c in chronic myelogenous leukemia (CML): hematologic, cytogenetic and molecular-genetic response of patients with chronic phase CML previously resistant to therapy with interferon gamma.

Authors:  F Herrmann; D Jonas; S G Helfrich; A Lindemann; E Schleiermacher; R Mertelsmann
Journal:  Blut       Date:  1990-10

9.  Development of plasma cell tumors during treatment of multiple myeloma.

Authors:  G Vaiopoulos; N Viniou; E Plata; K Konstantopoulos; A Andreopoulos; Y Rombos; J Meletis; D Loukopoulos; X Yataganas
Journal:  Ann Hematol       Date:  1996-05       Impact factor: 3.673
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.